Kathy S Albain

9PUBLICATIONS
119CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 07, 2026
Unlocking 30-Year-Old Archival Formalin-Fixed Paraffin-Embedded Breast Cancer Specimens (SWOG S8897): An Analytical Feasibility Study.

|Dec 02, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.

Lajos Pusztai, Jess R Hoag, Kathy S Albain

|Jun 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa

|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.

Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd

|Dec 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.

Kathy S Albain, Christina Yau, Emanuel F Petricoin

|Aug 24, 2023
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.

Delaney V Rutherford, Sarah Medley, Nicholas C Henderson

Pageof 2

Frequent Collaborators

6 joint publications

Lajos Pusztai

5 joint publications

William E Barlow

4 joint publications

James M Rae

4 joint publications

Gabriel N Hortobagyi